` REG1V (Revenio Group Oyj) vs DAX Index Comparison - Alpha Spread

R
REG1V
vs
D
DAX Index

Over the past 12 months, REG1V has underperformed DAX Index, delivering a return of -14% compared to the DAX Index's +20% growth.

Stocks Performance
REG1V vs DAX Index

Loading
REG1V
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
REG1V vs DAX Index

Loading
REG1V
DAX Index
Difference
www.alphaspread.com

Performance By Year
REG1V vs DAX Index

Loading
REG1V
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Revenio Group Oyj vs Peers

DAX Index
REG1V
ABT
ISRG
BSX
SYK
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Revenio Group Oyj
Glance View

Market Cap
599.9m EUR
Industry
Health Care

Revenio Group Oyj is a globally operating health technology, which engages in the detection of glaucoma, osteoporosis, skin cancer, and asthma. The company is headquartered in Vantaa, Etela-Suomen and currently employs 184 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.

REG1V Intrinsic Value
28.93 EUR
Undervaluation 22%
Intrinsic Value
Price
R
Back to Top